Legal & General Group
DBTX

Legal & General Group’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Legal & General Group’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,742
Closed -$15K – 3516
2021
Q2 		$15K Sell
1,742
-925
-35% -$8.16K ﹤0.01% 3384
2021
Q1 		$31K Buy
+2,667
New +$41.8K ﹤0.01% 2984

Other funds holding DBTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Legal & General Group's DBTX Position: Q3 2021 in Review

Legal & General Group sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2021, closing a stake of 1,742 shares — an estimated $15K sold.

Legal & General Group first reported a position in DBTX in Q1 2021 and held it in 2 quarters. The position peaked at $31K in Q1 2021. 36 funds tracked by Wall St. Rank hold DBTX as of Q3 2021.

  • Legal & General Group reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Legal & General Group sold 1,742 Decibel Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $15K.
  • Legal & General Group first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Legal & General Group's Decibel Therapeutics, Inc. Common Stock position peaked at $31K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.